Showing results (1-10 of 367) with videos related to
Sort By:
Pageof 37
Medrxiv : the Preprint Server for Health Sciences|July 30, 2026
Multi-omic Profiling of Recurrence Risk Across Breast Cancer SubtypesA Eden Cruikshank, Pooja Chandra, Christopher I Li, et al.Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arraysGavin Ha, Sohrab ShahMaturitas|September 8, 2004
Postmenopausal hormone therapy and the risk of breast cancer: the view of an epidemiologistChristopher I LiEthnicity & Disease|April 13, 2005
Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United StatesChristopher I LiHormones & Cancer|July 16, 2011
Discovery and validation of breast cancer early detection biomarkers in preclinical samplesChristopher I LiHormones & Cancer|July 16, 2011
Risk of mortality by histologic type of breast cancer in the United StatesChristopher I LiEuropean Journal of Case Reports in Internal Medicine|July 17, 2023
Are Patients with HHV-8 Associated Castleman Disease Successfully Treated with Rituximab at Risk of Subsequently Developing HHV-8 Negative (Idiopathic) Castleman Disease?Gavin Ha, Kelsey Kwong, Bryce Tanaka, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 15, 2015
Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 statusLu Chen, Christopher I LiCurrent Opinion in Rheumatology|March 20, 2021
Impact of rheumatoid arthritis and biologic and targeted synthetic disease modifying antirheumatic agents on cancer risk and recurrenceNamrata Singh, Christopher I LiHormones & Cancer|July 16, 2011
Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factorsJean A McDougall, Christopher I LiPageof 37